Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Compliance Officer - 2023-02-28
Chief Tech/Sci/R&D Officer 63 -
Date Insider Type Main position Quantity % Market Cap.
7/24/23 Tender

Chief Executive Officer

896,058 0.5908%
7/24/23
Insud Pharma SL
OthersCompany 2,551,020 1.6818%
7/24/23 Others 25,510 0.0168%
Change 5-day change 1-year change 3-year change Capi.($)
-0.03%+0.47% - - 45.43M
+0.18%-2.92%+0.07%+13.83% 48B
+6.03%+5.22%+420.33%+519.87% 41.13B
-2.21%-6.07%+24.87%+5.20% 37.56B
+2.94%-2.25%+6.15%+59.69% 35.91B
+1.98%+4.74%+12.19%+41.37% 29.86B
+0.47%-3.87% - - 16.12B
+0.31%+0.72%+32.99%+122.25% 16.05B
+0.70%+0.90%+3.99%+17.95% 13.76B
-0.98%-12.98%-4.82%-38.09% 12.1B
Average +0.94%-1.81%+61.97%+92.76% 27.83B
Weighted average by Cap. +1.40%-0.93%+82.50%+116.77%
Logo GreenLight Biosciences Holdings
GreenLight Biosciences Holdings, PBC is a pre-commercial stage biotechnology company. The Company has a cell-free ribonucleic acid (RNA) production platform for the discovery, development, and commercialization of products to promote healthier plants, foods, and people. The Company's cell-free biomanufacturing platform enables the making of complex biological molecules-nucleic acids, peptides, carbohydrates, and many others using fermentation. Its technology platform provides integrated discovery, design, and development of RNA-based products used in advanced pharma discovery to agriculture and human health. It has developed two manufacturing processes, one for plant health (dsRNA) and one for human health (mRNA) that both rely on synthesis of RNA from RNA building blocks, enzymes, and deoxyribonucleic acid (DNA) templates. The Company's plant program includes the Colorado Potato Beetle Program-Calantha; Varroa Mite Program, and Powdery Mildew Complex.
Employees
-
  1. Stock Market
  2. Stocks
  3. GRNA Stock